Cystic fibrosis-related diabetes testing in Massarosa
Find health labs to test for Cystic fibrosis-related diabetes in Massarosa and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Ospedale Cottolengo
Via San Giuseppe Benedetto Cottolengo, 9, 56125 Pisa PI, Italia
11 km
Unverified
A Diabetes Test costs €15.00
See Details
Hemoglobin Test by Farmacia Picconi
Via Provinciale Montalbano, 371, 51034 Serravalle Pistoiese PT, Italia
24.5 km
Hemoglobin Test by Farmacia Etrusca
Via Pistoiese, 174, 59100 Prato PO, Italia
37.6 km
Diabetes Test by Centro analisi cliniche Madonie
Via Antonio Gramsci, 39, 50019 Sesto Fiorentino FI, Italia
42.8 km
Hemoglobin Test by Synlab
Piazza della Stazione, 2, 50123 Firenze FI, Italia
46.1 km
Hemoglobin Test by Synlab
Piazza Dante Alighieri, 63, 50032 Borgo San Lorenzo FI, Italia
52.4 km
Hemoglobin Test by Farmacia Beata Vergine della Salute
Corso Canalchiaro, 127, 41121 Modena MO, Italia
61 km
Diabetes Test by Casa della Salute
Via San Benedetto, 20, 50066 Reggello FI, Italia
61 km
Hemoglobin Test by Farmacia Pian di Macina
Via Ottavio Garganelli, 13, 40065 Pianoro BO, Italia
61.2 km
Hemoglobin Test by Bianalisi - Punto prelievo Rapallo
Via Pellerano Murtula, 1, 16035 Rapallo GE, Italia
64.3 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
